Press release
🌐 ALS Treatment Market to Hit $1.04 Billion by 2032 | Driven by New Drug Approvals & Asia-Pacific Expansion
Amyotrophic Lateral Sclerosis Treatment Market
The global amyotrophic lateral sclerosis (ALS) treatment market was valued at $662.3 million in 2022 and is projected to reach $1,038.94 million by 2032, growing at a CAGR of 4.6% (2023-2032). ALS, a progressive neurodegenerative disease, continues to drive demand for new therapies amid rising global prevalence.
Get a Sample Copy of this Report: https://www.alliedmarketresearch.com/request-sample/A10244
🔍 Key Market Drivers
Rising Prevalence: Europe leads with a prevalence of 6.22 per 100,000, fueling demand for treatment.
Emerging Markets: Asia-Pacific, Latin America, and Africa offer growth potential through improved infrastructure and awareness.
FDA Approvals: Recent approvals of RELYVRIO (Amylyx, 2022) and RADICAVA ORS (Mitsubishi Tanabe, 2022) are expanding treatment portfolios.
R&D Momentum: Robust funding is accelerating gene therapy and stem cell research.
Early Diagnosis: Advocacy and tech advancements are enabling faster intervention.
⚠ Market Challenges
Limited FDA-Approved Drugs: Only Riluzole and Edaravone approved to date.
Diagnostic Delays: ALS symptoms often mimic other conditions.
Drug Side Effects: Issues like nausea, diarrhea, and infections affect adherence.
🧪 Market Segmentation
By Drug:
Riluzole - Market leader.
Edaravone (RADICAVA ORS) - Gaining momentum.
Others (RELYVRIO) - Poised for rapid growth.
By ALS Type:
Sporadic ALS (90-95%) - Dominant segment.
Familial ALS - Fastest-growing due to genetic advancements.
By Distribution:
Retail Pharmacies - Largest share.
Online - Fastest-growing.
By Region:
North America - Leading due to R&D and healthcare access.
Asia-Pacific - Fastest-growing region.
Europe - Stable growth.
LAMEA - Emerging potential.
🏢 Key Players
Amylyx Pharmaceuticals
Mitsubishi Tanabe Pharma
Aquestive Therapeutics
Glenmark, Sun Pharma, Viatris, Covis Pharma, ITALFARMACO, Alkem
📈 Recent Developments
RADICAVA ORS launched in the U.S. (June 2022)
RELYVRIO FDA-approved (September 2022)
Amylyx-Neopharm Partnership for Israel & Palestine (January 2023)
🔮 Outlook to 2032
ALS treatment market growth will be shaped by:
Innovative pipelines (gene & stem cell therapies)
Emerging market expansion
Increased advocacy and diagnostics
💡 Market Takeaways:
Market Size (2032): $1.04 billion
Top Drug: Riluzole
Fastest-Growing Region: Asia-Pacific
Biggest Challenge: Drug limitations & late diagnosis
Key Opportunities: Drug innovation & global access
Enquire Before Buying: https://www.alliedmarketresearch.com/purchase-enquiry/A10244
Contact:
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int'l: +1-503-894-6022
Toll Free: + 1-800-792-5285
UK: +44-845-528-1300
India (Pune): +91-20-66346060
Fax: +1-800-792-5285
help@alliedmarketresearch.com
About Us:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP, based in Portland, Oregon. AMR provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients in making strategic business decisions and achieving sustainable growth in their respective market domains.
AMR launched its user-based online library of reports and company profiles, Avenue. An e-access library is accessible from any device, anywhere, and at any time for entrepreneurs, stakeholders, researchers, and students at universities. With reports on more than 60,000 niche markets with data comprising 600,000 pages along with company profiles on more than 12,000 firms, Avenue offers access to the entire repository of information through subscriptions. A hassle-free solution to clients' requirements is complemented with analyst support and customization requests.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release 🌐 ALS Treatment Market to Hit $1.04 Billion by 2032 | Driven by New Drug Approvals & Asia-Pacific Expansion here
News-ID: 4039774 • Views: …
More Releases from Allied Market Research
Liability Insurance Market Global Opportunity Analysis and Industry Forecast, 20 …
Allied Market Research published a report, titled, "Liability Insurance Market by Coverage Type (General Liability Insurance, Professional Liability Insurance, Insurance for Directors and Officers), by Enterprise Size (Medium-sized Enterprises, Large Enterprises, Small Enterprises), by Application (Commercial, Personal): Global Opportunity Analysis and Industry Forecast, 2021-2031." According to the report, the global liability insurance industry generated $252.34 billion in 2021, and is expected to reach $432.81 billion by 2031, witnessing a CAGR…
Umbrella Insurance Market to Hit $170.7 Billion by 2031, Growing at 9.2% CAGR
Umbrella insurance is a form of casualty insurance designed to shield individuals from significant liability claims that surpass the coverage limits of their primary commercial general liability, business auto, and other business insurance policies. It offers a cost-effective solution for significantly increasing liability limits, providing added protection against catastrophic claims in today's unpredictable environment.
Request Sample Pages Now: https://www.alliedmarketresearch.com/request-sample/15130
Allied Market Research published a report, titled, "Umbrella Insurance Market Size by Coverage…
Bancassurance Market to Reach $1.8 Trillion by 2031, Growing at 7.4% CAGR
Allied Market Research published a report, titled, "Bancassurance Market by Insurance Type (Life Insurance, Non-Life Insurance), by Model Type (Pure Distributor Model, Strategic Alliance Model, Joint Venture Model, Financial Holding, Others), by End User (Personal, Business): Global Opportunity Analysis and Industry Forecast, 2021-2031" According to the report, the global bancassurance industry generated $901.5 billion in 2021, and is estimated to reach $1.8 trillion by 2031, witnessing a CAGR of 7.4%…
Lendtech Market to Reach $61.9 Billion by 2031, Growing at 23.2% CAGR
Allied Market Research published a report, titled, "LendTech Market by Component (Solution and Services), Deployment Mode (On-Premises and Cloud), Type (Consumer Lending and Business Lending), Organization Size (Large Enterprises and Small and Medium-sized Enterprises), and End User (Banks, Insurance Companies, Credit Unions and NBFCs) And Region (North America, Europe, Asia-Pacific, and LAMEA): Global Opportunity Analysis and Industry Forecast, 2022-2031" According to the report, the global lendtech industry generated $8 billion…
More Releases for ALS
Amyotrophic Lateral Sclerosis (ALS) Treatment Market: Insights and Emerging Tren …
Amyotrophic Lateral Sclerosis (ALS) Treatment Market valued at USD X.X Billion in 2024 and is projected to reach USD X.X Billion by 2032, growing at a CAGR of X.X% from 2025 to 2032.
What are the potential factors for the growth of the ambulance services market?
The ambulance services market is witnessing steady growth driven by rising incidences of chronic diseases, road accidents, and medical emergencies requiring immediate care. Increasing awareness about…
Amyotrophic Lateral Sclerosis (ALS) Market Size, Trends & Share 2034
Market Overview:
The Amyotrophic Lateral Sclerosis (ALS) market reached a value of US$ 494.1 Million in 2023 and expected to reach US$ 715.4 Million by 2034, exhibiting a growth rate (CAGR) of 3.4% during 2024-2034.
The report offers a comprehensive analysis of the amyotrophic lateral sclerosis market in the United States, EU5 (including Germany, Spain, Italy, France, and the United Kingdom), and Japan. It covers aspects such as treatment methods, drugs available…
Unlocking the ALS Market: Insights, Trends, and Growth Prospects
Amyotrophic Lateral Sclerosis (ALS) is a devastating neurological condition that progressively damages motor neurons in the brain and spinal cord. It results in muscle weakness, paralysis, and, ultimately, respiratory failure. The ALS market has gained significant attention due to its growing global prevalence.
In 2023, the ALS market was valued at USD 716.3 million. This valuation is not just a monetary figure; it represents the economic and healthcare burden of ALS.…
ALS Contract Services joins J. Mallinson (Ormskirk) Ltd
J. Mallinson is extremely delighted to announce that following a period of extensive searching for a specialist strategic business partner, they have purchased ALS Contract Services from Agrovista, a leading supplier of agronomy advice, seed, crop protection products and precision farming services for an undisclosed fee. The acquisition will protect the long-term future of ALS and the business will provide a workforce of 35 in construction and sports pitch management…
ALS Contract Services joins J. Mallinson (Ormskirk) Ltd
J. Mallinson is extremely delighted to announce that following a period of extensive searching for a specialist strategic business partner, they have purchased ALS Contract Services from Agrovista, a leading supplier of agronomy advice, seed, crop protection products and precision farming services for an undisclosed fee. The acquisition will protect the long-term future of ALS and the business will provide a workforce of 35 in construction and sports pitch management…
Food Certification Market Future Growth Outlook | Intertek, BV, ALS
Latest survey on Food Certification Market is conducted to provide hidden gems performance analysis to better demonstrate competitive environment of Food Certification. The study is a mix of quantitative market stats and qualitative analytical information to uncover market size revenue breakdown by key business segments and end use applications. The report bridges the historical data from 2015 to 2020 and forecasted till 2026*, the outbreak of latest scenario in Food…
